Literature DB >> 8500748

Hepatoprotective properties of ursodeoxycholic acid.

D M Heuman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8500748     DOI： 10.1016/0016-5085(93)90672-y

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  14 in total

Review 1.  Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.

Authors:  Bader Alenezi; Esther Lamoureux; Lesley Alpert; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  The ursodeoxycholic acid story in primary biliary cirrhosis.

Authors:  A G Lim; R P Jazrawi; T C Northfield
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.

Authors:  H Bécheur; H Dall'osto; G Chatellier; M C Charton-Bain; J M Aubertin; A Attar; F Bloch; J P Petite
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

Review 4.  Ursodeoxycholic acid treatment of vanishing bile duct syndromes.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

5.  Ursodeoxycholic acid and primary biliary cirrhosis.

Authors:  A G Lim; T C Northfield
Journal:  BMJ       Date:  1994 Aug 20-27

Review 6.  Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review.

Authors:  David Q-H Wang; Martin C Carey
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

7.  Ursodeoxycholic acid and in vitro vasoactivity of hydrophobic bile acids.

Authors:  A Bomzon; P Ljubuncic
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

8.  Effect of oral naltrexone on pruritus in cholestatic patients.

Authors:  Fariborz Mansour-Ghanaei; Amir Taheri; Hossein Froutan; Hadi Ghofrani; Mohsen Nasiri-Toosi; Amir-Hossein Bagherzadeh; Mohammad-Jafar Farahvash; Shahram Mirmomen; Naser Ebrahimi-Dariani; Elham Farhangi; Zahra Pourrasouli
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 9.  Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed.

Authors:  Michele Pier Luca Guarino; Silvia Cocca; Annamaria Altomare; Sara Emerenziani; Michele Cicala
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

10.  Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.

Authors:  M C Bateson; P Gedling
Journal:  Postgrad Med J       Date:  1998-08       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.